EUVIMEDEUVIMED entdecken
Crossref

Palliative care for interstitial lung disease: A nationwide survey of pulmonary specialists

Tomoyuki Fujisawa iD, Norimichi Akiyama, Tatsuya Morita, Takafumi Koyauchi iD, Yoshinobu Matsuda iD, Masanori Mori, Mitsunori Miyashita, Ryo Tachikawa, Keisuke Tomii, Hiromi Tomioka iD, Satoshi Hagimoto, Yasuhiro Kondoh iD und 2 weitere

Respirology · 2023

DOI: 10.1111/resp.14493 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Respirology, 2023. Verfasst von Tomoyuki Fujisawa und 13 weiteren Autor:innen. Beteiligte Einrichtung: Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama Higashi-ku, Hamamatsu, 431-3192, Japan. Hauptthemen laut MEDLINE: Lung Diseases, Interstitial, Lung Neoplasms. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Ministry of Health, Labour and Welfare.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objective Interstitial lung disease (ILD) is progressive with high symptom burdens and poor prognosis. Patients with ILD need optimal palliative care to maintain their quality of life, however, few nationwide surveys have addressed palliative care for ILD.

Methods

A nationwide, self‐administered questionnaire was conducted. Questionnaires were sent by mail to pulmonary specialists certified by the Japanese Respiratory Society ( n = 3423). The current practices of PC for ILD, end‐of‐life communication, referral to a PC team, barriers to PC for ILD, and comparison of PC between ILD and lung cancer (LC).

Results

1332 (38.9%) participants completed the questionnaire, and the data of 1023 participants who had cared for ILD patients in the last year were analysed. Most participants reported that ILD patients often or always complained of dyspnoea and cough, but only 25% had referred them to a PC team. The timing of end‐of‐life communication tended to be later than the physician‐perceived ideal timing. The participants experienced significantly greater difficulty in symptomatic relief and decision‐making in PC for ILD compared to LC. Prescription of opioids for dyspnoea was less frequent for ILD than for LC. ILD‐specific barriers in PC included an ‘inability to predict prognosis’, ‘lack of established treatments for dyspnoea’, ‘shortage of psychological and social support’, and ‘difficulty for patients/families to accept the disease's poor prognosis’.

Conclusion

Pulmonary specialists experienced more difficulty in providing PC for ILD compared to LC and reported considerable ILD‐specific barriers in PC. Multifaceted clinical studies are needed to develop optimal PC for ILD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung Diseases, InterstitialLung NeoplasmsHumansPalliative CareQuality of LifeDyspneaSurveys and QuestionnairesDeath

Stichwörter der Autor:innen

ILDdyspnoeaend-of-life communicationinterstitial lung diseasepalliative caresymptom relief

Autor:innen und Institutionen

  • Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama Higashi-ku, Hamamatsu, 431-3192, Japan.
  • Department of Pulmonary Medicine, Fujieda Municipal General Hospital, 4-1-11 Surugadai, Fujieda, 426-8677, Japan.
  • Palliative and Supportive Care Division, Seirei Mikahahara General Hospital, 3453 Mikatahara, Kita-ku, Hamamatsu, 433-8558, Japan.
  • Clinical Research Center, National Hospital Organization Kinki-Chuo Chest Medical Center, 1180 Nagasone-cho, Kita-ku, Sakai, Osaka, 591-8555, Japan.
  • Department of Psychosomatic Internal Medicine, National Hospital Organization Kinki-Chuo Chest Medical Center, 1180 Nagasone-cho, Kita-ku, Sakai, Osaka, 591-8555, Japan.
  • Department of Palliative Nursing, Health Sciences, Tohoku University Graduate School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8575, Japan.

ORCID-Profile: Tomoyuki Fujisawa, Takafumi Koyauchi, Yoshinobu Matsuda, Hiromi Tomioka, Yasuhiro Kondoh

Förderung

  • Ministry of Health, Labour and Welfare

Zitieren

APA

Fujisawa, T., Akiyama, N., Morita, T., Koyauchi, T., Matsuda, Y., Mori, M., Miyashita, M., Tachikawa, R., Tomii, K., Tomioka, H., Hagimoto, S., Kondoh, Y., Inoue, Y., & Suda, T. (2023). Palliative care for interstitial lung disease: A nationwide survey of pulmonary specialists. Respirology. https://doi.org/10.1111/resp.14493

Vancouver

Fujisawa T, Akiyama N, Morita T, Koyauchi T, Matsuda Y, Mori M, et al. Palliative care for interstitial lung disease: A nationwide survey of pulmonary specialists. Respirology. 2023. doi:10.1111/resp.14493

BibTeX
@article{Fujisawa2023,
  author = {Fujisawa, Tomoyuki and Akiyama, Norimichi and Morita, Tatsuya and Koyauchi, Takafumi and Matsuda, Yoshinobu and Mori, Masanori and Miyashita, Mitsunori and Tachikawa, Ryo and Tomii, Keisuke and Tomioka, Hiromi and Hagimoto, Satoshi and Kondoh, Yasuhiro and Inoue, Yoshikazu and Suda, Takafumi},
  title = {Palliative care for interstitial lung disease: A nationwide survey of pulmonary specialists},
  journal = {Respirology},
  year = {2023},
  doi = {10.1111/resp.14493}
}
Kostenlos starten →